A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia
Romiplostim and eltrombopag, the first thrombopoietic receptor-agonists with demonstrated efficacy against immune thrombocytopenia in prospective controlled studies, were recently authorized in most countries for adults with chronic immune thrombocytopenia. So far, no data are available about the po...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Ferrata Storti Foundation
2013-06-01
|
| Серии: | Haematologica |
| Online-ссылка: | https://haematologica.org/article/view/6688 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|